Cancers in other organ systems (e.g. pancreas cancer, lung cancer) have shown an interdependence between KrasG12D mutation and heightened STAT3 activity [38, 39], and it has also been shown that estradiol functions to increase STAT3 activation [40]. Here, STAT3 is linked to cancer.